ArticleFrontiers in pharmacology2022

Real-Life Experience of Regorafenib in Patients With Advanced Hepatocellular Carcinoma.

Jing-Yu Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.